• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition, Swallowing and Saliva
      • Activities of Daily Living and Occupational Therapy
      • Muscles, Mobility and Exercise
      • Respiratory Care
      • Speech and Communication
      • Voice Preservation
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
  • Members
    • Member Registration
    • Forgot Password

Gudjon_Iceland

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Forum Replies Created

Viewing 1 post (of 1 total)
  • Author
    Posts
  • September 29, 2016 at 10:06 pm in reply to: Newcomer #2167
    Gudjon_Iceland
    Participant

      Greetings to you as well my dear friends from Turkey and around the world.

    • Author
      Posts
    Viewing 1 post (of 1 total)

    Primary Sidebar

    Advocacy

    • Advocacy Toolkit

    Approved Drugs

    • Nuedexta
    • Radicava/Edaravone
    • Riluzole/Tiglutik
    • Rozebalamin / Methylcobalamin
    • Tofersen/Qalsody

    Drugs in Development

    • AB Science – Masitinib
    • NurOwn
    • Clene Nanomedicine – CNM-Au8
    • ILB
    • Kadimastem – AstroRx
    • Neuronata-R / Lenzumestrocel
    • NeuroSense – PrimeC
    • NP001
    • Prilenia Therapeutics – Pridopidine
    • SOD1 Therapies & Trials
    • SPG302
    • Regulatory T Cell Enhancing Therapies
    • Ulefnersen

    Care services

    • Genetic Counselling & Testing
    • Mental Health Support
    • Nursing and Symptom Management
    • Nutrition, Swallowing and Saliva
    • Activities of Daily Living and Occupational Therapy
    • Muscles, Mobility and Exercise
    • Respiratory Care
    • Speech and Communication
    • Support for Family & Caregivers
    • Technology

    Support for members

    • Alliance Support Grant
    • About the meetings

    Programs & Events

    • Calendar of Events/Programs
    • Alliance Webinars
    • Alliance Meeting
    • Allied Professionals Forum
    • ALS/MND Connect
    • Global Day Calendar
    • March of Faces
    • International Symposium

    About

    • Who We Are
    • Board of Trustees
    • Councils, Forums & Committees
      • PALS and CALS Advisory Council
      • Scientific Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
      • Meetings
    • Awards

    Upcoming Events

    Oct 13
    8:00 am - 9:00 am EDT

    Member Forum: Technology Solutions for PALS

    Oct 13
    6:00 pm - 7:00 pm EDT

    Member Forum: Technology Solutions for PALS

    Oct 15
    9:00 am - 10:00 am EDT

    Webinar: The Use of AI in ALS/MND

    Oct 17
    2:00 pm - 3:00 pm EDT

    ALS Association Webinar: So, What’s Next? Understanding the Decisions along an ALS Journey

    Oct 21
    7:00 am - 8:30 am EDT

    Member Roundtable: Defining Rights in the Genetics Era of ALS/MND

    View Calendar

    • Francisco Perez Palop, Spain

      Francisco Perez Palop, Spain

    • Jeff Sutherland, Canada

      Jeff Sutherland, Canada
      jspic

    • Christian Bär, Germany

      Christian Bär, Germany

    • Roxana Canova, Argentina

      Roxana Canova, Argentina

    • Bruno Leanza Mantegna, Italy

      Bruno Leanza Mantegna, Italy

    • Timothy Holman, Switzerland

      Timothy Holman, Switzerland

    • Andrietta, Italy

      Andrietta, Italy
      Andrietta

    • Olga Cosentino, Argentina

      Olga Cosentino, Argentina

    • Malu Araujo Ribeiro, Brazil

      Malu Araujo Ribeiro, Brazil

    • Philip Brindle, England

      Philip Brindle, England

    • Jose Espinosa, Argentina

      Jose Espinosa, Argentina

    • Mike Rannie, Canada

      Mike Rannie, Canada

    • Graham Johnson, Australia

      Graham Johnson, Australia

    • Norm MacIsaac, Canada

      Norm MacIsaac, Canada

    • Eddy Lefrancois, Canada

      Eddy Lefrancois, Canada

    • Natalya Rybakova, Russia

      Natalya Rybakova, Russia

    • Shay Rishoni, Netherlands

      Shay Rishoni, Netherlands

    • Claudia Gotti, Brazil

      Claudia Gotti, Brazil

    • Lee Millard, England

      Lee Millard, England

    • Gudjon Sigurdsson, Iceland

      Gudjon Sigurdsson, Iceland

    • Anna Barrow, UK

      Anna Barrow, UK

    • Fernando Ocampo Cardona, Colombia

      Fernando Ocampo Cardona, Colombia

    • Chun Ju Xiao, China

      Chun Ju Xiao, China

    • Erwin Coppejans, Belgium

      Erwin Coppejans, Belgium

    • Dan Doctoroff, USA

      Dan Doctoroff, USA

    • John Sweeney, USA

      John Sweeney, USA

    • Jette Odgaard Villemoes, Denmark

      Jette Odgaard Villemoes, Denmark

    • Murat Morali, Turkey

      Murat Morali, Turkey

    • Rosie Riley, USA

      Rosie Riley, USA

    • Olga, Argentina

      Olga, Argentina

    • Torben Mikkelsen, Denmark

      Torben Mikkelsen, Denmark

    • Denis Blais, Canada

      Denis Blais, Canada

    • Inta Grubb, Australia

      Inta Grubb, Australia

    • Chen Yin Xue, Taiwan

      Chen Yin Xue, Taiwan

    • Bob Spurrier, USA

      Bob Spurrier, USA

    • Joy Blakeley, Australia

      Joy Blakeley, Australia

    • Jo Knowlton, Scotland

      Jo Knowlton, Scotland

    • Andrew Langat, Kenya

      Andrew Langat, Kenya

    • PALS and CALS, Singapore

      PALS and CALS, Singapore

    • Guido De Mets, Belgium

      Guido De Mets, Belgium

    • Margreth Burger-Saile, Switzerland

      Margreth Burger-Saile, Switzerland

    • Orlando Ruiz, Colombia

      Orlando Ruiz, Colombia

    • Anthony Lynch, Australia

      Anthony Lynch, Australia

    • Kirsty Gerlach, New Zealand

      Kirsty Gerlach, New Zealand

    • Colm Francis Davis, Ireland

      Colm Francis Davis, Ireland

    • Anita Forte, USA

      Anita Forte, USA

    • Teddy Hanono Annie, Mexico

      Teddy Hanono Annie, Mexico

    • Ali Var, Turkey

      Ali Var, Turkey

    • Marco Antonio Alvarez Mercado, Mexico

      Marco Antonio Alvarez Mercado, Mexico

    • Alberto Baez Murillo, Colombia

      Alberto Baez Murillo, Colombia

    Learn more about the March of Faces

    Coronavirus (COVID-19) Resources

    Instructions

    First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

    If you have already registered, please use the details provided to log in using this form.

    Drugs No Longer in Development

    • AMX0035
    • Reldesemtiv
    • Arimoclomol
    • TUDCA

    Footer

    Stay connected to the global ALS/MND community.

    Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

     
    This field is for validation purposes and should be left unchanged.
    • Email
    • Facebook
    • LinkedIn
    • Twitter
    • YouTube
    Return to top of page

    Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

    Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


    Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login